Atlas Trials

Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma

Clinical trial NCT04565327 · TERMINATED

Trial details

NCT number
NCT04565327
Sponsor
Zhen Wang, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2020-08-14
Primary completion
2022-11-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.